Navigation Links
Honor Society of Nursing Recognizes Researcher of HIV Risk Prevention for Poor and Underserved
Date:11/6/2007

INDIANAPOLIS and DEERFIELD, Ill., Nov. 6 /PRNewswire-FirstCall/ -- In recognition of her research and development of strategies to reduce HIV risk-associated sexual behaviors among African-American, South-African and Latino youth and adults, the Honor Society of Nursing, Sigma Theta Tau International, announced the selection of Loretta Sweet Jemmott, PhD, RN, FAAN, to receive The Baxter International Foundation's 2007 Episteme Award.

Jemmott was presented with the $15,000 award at a special ceremony at the honor society's biennial convention, held November 2-7, 2007, in Baltimore, Md. The Baxter International Foundation sponsors the Episteme Award, presented and selected by the honor society.

Jemott is professor and director of the Center for Health Disparities Research at the University of Pennsylvania School of Nursing. She has built an internationally recognized program of research on HIV prevention interventions for poor and underserved populations.

Jemott developed the "Sister to Sister HIV Risk-Reduction Intervention," an evidenced-based, 20-minute HIV risk-reduction intervention program. The intervention is culturally sensitive, engaging, and gender specific, and can be integrated into primary care clinical practices by nurses and other health care providers. The one-on-one skill-building exercises stress the importance of using condoms to reduce the risk of sexually transmitted infections and HIV.

Jemott's multifaceted research integrates reasoned action, planned behaviors and social cognition with five goals: explain the underlying social psychology factors that create risky sexual behavior; identify theory-based, culturally sensitive and developmentally appropriate strategies to reduce risk; test the effectiveness of interventions using scientifically rigorous methodologies and experimental design; answer practical questions regarding effective implementation; and disseminate evidence-based curricula.

Jemmott has received numerous awards for her significant contributions to the profession, the field of HIV prevention research and the community, including recognition from the National Institutes of Health and the Centers for Disease Control and Prevention. She has been published in more than 70 peer-reviewed articles and books.

Jemmott received a bachelor of science in nursing from the Hampton Institute of Nursing, and a master of science in nursing and doctoral degree in human sexuality education from the University of Pennsylvania. Her campus positions at the University of Pennsylvania include assistant provost for gender and minority equity issues and co-chair of the Center for AIDS Research Behavior and Social Science Research Core.

About The Episteme Award

The Baxter International Foundation's Episteme Award acknowledges a major breakthrough in nursing knowledge development that has resulted in a significant and recognizable benefit to the public. In the tradition of the Nobel Prize, the Episteme Award is presented to a person or team for highly significant research.

About The Honor Society of Nursing

The Honor Society of Nursing, Sigma Theta Tau International, is a not-for-profit organization whose mission is to improve the health of people worldwide through leadership and scholarship in practice, education and research. Founded in 1922, the Honor Society of Nursing has inducted more than 345,000 members. Members are active in 119 countries and include practicing nurses, instructors, researchers, policymakers, entrepreneurs and others. The society's 446 chapters are located at 535 institutions of higher education throughout the United States, as well as Australia, Botswana, Brazil, Canada, Ghana, Hong Kong, Japan, Kenya, Malawi, Mexico, the Netherlands, Pakistan, South Africa, South Korea, Swaziland, Sweden, Taiwan and Tanzania. For more information, please visit http://www.honorsociety.org.

About The Baxter International Foundation

The Baxter International Foundation, the philanthropic arm of Baxter International Inc., helps organizations expand access to healthcare in the United States and around the world. The foundation, established in 1981, began to focus exclusively on increasing access to health care in 2002 -- particularly for the disadvantaged and underserved -- in communities where Baxter employees live and work. Baxter International Inc. (NYSE: BAX), through its subsidiaries, assists health care professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives. For more information, please visit http://www.baxter.com.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
6. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
7. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Now in its seventh year, the ... most successful at developing and commercialising innovation. ... The Index can be ... to two different companies in early phase, which would make ... analysis of each company,s performance between 2011 and 2016, the 2017 ranking ...
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/27/2017)... The Dutch secure mobile phone ... at the security level RESTRICTED. The solution thus meets the ... the communication of classified information. ... Sectra and Samsung have a strategic ... solution. Sectra Tiger/R is developed by Sectra under guidance from ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate ... and video system brings songs, movies, TV shows and much more apps for user ... high-definition sound. An immersive view of 1280 x 720 provides crisp images with remarkable ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud ... The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in drug ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top ... and genders. And the need for advanced services is growing. , Project WE ... care program, in collaboration with their non-profit partners in their fight against cancer and ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for ... analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements ...
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
Breaking Medicine News(10 mins):